Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
After-Hours: 20:00
Organon Max Drawdown (5Y) : 82.70% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 82.70% |
| August 31, 2026 | 82.70% |
| July 31, 2026 | 82.70% |
| June 30, 2026 | 82.70% |
| May 31, 2026 | 82.70% |
| April 30, 2026 | 82.70% |
| March 31, 2026 | 82.70% |
| February 28, 2026 | 80.86% |
| January 31, 2026 | 80.86% |
| December 31, 2025 | 80.86% |
| November 30, 2025 | 80.86% |
| October 31, 2025 | 80.86% |
| September 30, 2025 | 75.78% |
| August 31, 2025 | 75.78% |
| July 31, 2025 | 75.78% |
| June 30, 2025 | 75.78% |
| May 31, 2025 | 75.78% |
| April 30, 2025 | 69.57% |
| March 31, 2025 | 69.57% |
| February 28, 2025 | 69.57% |
| January 31, 2025 | 69.57% |
| December 31, 2024 | 69.57% |
| November 30, 2024 | 69.57% |
| October 31, 2024 | 69.57% |
| September 30, 2024 | 69.57% |
| Date | Value |
|---|---|
| August 31, 2024 | 69.57% |
| July 31, 2024 | 69.57% |
| June 30, 2024 | 69.57% |
| May 31, 2024 | 69.57% |
| April 30, 2024 | 69.57% |
| March 31, 2024 | 69.57% |
| February 29, 2024 | 69.57% |
| January 31, 2024 | 69.57% |
| December 31, 2023 | 69.57% |
| November 30, 2023 | 69.57% |
| October 31, 2023 | 59.91% |
| September 30, 2023 | 55.03% |
| August 31, 2023 | 48.41% |
| July 31, 2023 | 48.41% |
| June 30, 2023 | 48.41% |
| May 31, 2023 | 48.41% |
| April 30, 2023 | 43.41% |
| March 31, 2023 | 43.41% |
| February 28, 2023 | 39.76% |
| January 31, 2023 | 39.76% |
| December 31, 2022 | 39.76% |
| November 30, 2022 | 39.76% |
| October 31, 2022 | 39.76% |
| September 30, 2022 | 39.53% |
| August 31, 2022 | 26.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Merck & Co., Inc. | 43.45% |
| Pfizer Inc. | 58.95% |
| Bristol Myers Squibb Co. | 47.67% |
| Harmony Biosciences Holdings, Inc. | 68.48% |
| ANI Pharmaceuticals, Inc. | 72.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.92 |
| Beta (5Y) | 1.549 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.23% |
| Historical Sharpe Ratio (5Y) | -0.2639 |
| Historical Sortino (5Y) | -0.5611 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.62% |